0
Signin
countryflagUK

8082-737-676

0R15 9080.0 -2.7837% 0R1E 9565.0 0.0% 0M69 None None% 0R2V 236.5 0.0% 0QYR 1560.0 -0.7634% 0QYP 417.0 0.0% 0RUK None None% 0RYA 1557.0 -1.2056% 0RIH 193.8 0.0% 0RIH 193.8 0.0% 0R1O 217.5 9900.0% 0R1O None None% 0QFP 10742.2305 113.1395% 0M2Z 288.5555 -0.1106% 0VSO 32.32 -9.2262% 0R1I None None% 0QZI 595.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 232.81 1.9755%

Kiniksa Pharmaceuticals Ltd

Healthcare US KNSA

18.73USD
0.39(2.13%)

Last update at 2025-01-15T19:09:00Z

Day Range

18.5819.05
LowHigh

52 Week Range

13.5622.09
LowHigh

Fundamentals

  • Previous Close 18.34
  • Market Cap1350.70M
  • Volume190595
  • P/E Ratio146.46
  • Dividend Yield-%
  • EBITDA-28.33100M
  • Revenue TTM301.77M
  • Revenue Per Share TTM4.29
  • Gross Profit TTM 173.21M
  • Diluted EPS TTM0.13

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 11.03M -156.53900M -156.22900M -163.91400M -103.44100M
Minority interest - - - - -
Net income 183.36M -157.92400M -161.38100M -161.86700M -103.22700M
Selling general administrative 97.95M 85.95M 45.32M 34.96M 21.56M
Selling and marketing expenses - - - - -
Gross profit 173.21M 29.44M - - 0.00000M
Reconciled depreciation 2.40M 2.35M 2.40M 2.07M 0.29M
Ebit 7.37M -158.99100M -159.76800M -172.03100M -108.44600M
Ebitda 9.77M -156.63600M -157.36300M -169.96300M -108.16000M
Depreciation and amortization 2.40M 2.35M 2.40M 2.07M 0.29M
Non operating income net other 1.25M 0.10M 1.13M 6.05M 4.72M
Operating income 7.37M -156.63600M -157.36300M -169.96300M -108.16000M
Other operating expenses 210.41M 195.18M 157.36M 169.96M 108.16M
Interest expense 1.25M 2.45M 3.54M 8.12M 0.00000M
Tax provision -172.33700M 1.39M 5.15M -2.04700M -0.21400M
Interest income 1.25M 0.10M 1.13M 6.05M 4.72M
Net interest income 1.25M 0.10M 1.13M 6.05M 4.72M
Extraordinary items - - - - -
Non recurring - 0.83M - - -
Other items - - - - -
Income tax expense -172.33700M 1.39M 5.15M -2.04700M -0.21400M
Total revenue 220.18M 38.54M 0.00000M 0.00000M 0.00000M
Total operating expenses 163.44M 186.08M 157.36M 169.96M 108.16M
Cost of revenue 46.97M 9.10M - - 0.00000M
Total other income expense net 3.65M 0.10M 1.13M 6.05M 4.72M
Discontinued operations - - - - -
Net income from continuing ops 183.36M -157.92400M -161.38100M -161.86700M -103.22700M
Net income applicable to common shares 183.36M -157.92400M -161.38100M -161.86700M -103.22700M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 526.32M 459.67M 232.80M 349.46M 254.53M
Intangible assets 17.25M 18.25M 19.25M - -
Earning assets - - - - -
Other current assets 17.54M 10.54M 6.58M 9.56M 8.25M
Total liab 87.48M 63.52M 47.76M 37.53M 29.11M
Total stockholder equity 438.84M -492.03400M -675.39700M -517.47300M -356.09200M